Ingevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) Current ratio
Ingevity Corporation's current ratio at the end of the quarter to 30 June 2026 was 1.6×, up 0.3× from fiscal 2025 (1.3×). Over the past ten years it has ranged from 1.3× (fiscal 2025) to 3.0× (fiscal 2015) — the current reading is the lowest in ten years. That is below the Specialty Chemicals industry median of 2.3× and below the Basic Materials sector median of 2.5×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.3× | (28.74%) |
| FY2024 | 1.9× | 2.90% |
| FY2023 | 1.8× | (19.39%) |
| FY2022 | 2.3× | (16.48%) |
| FY2021 | 2.7× | (4.21%) |
| FY2020 | 2.8× | 30.93% |
| FY2019 | 2.1× | (6.80%) |
| FY2018 | 2.3× | (4.18%) |
| FY2017 | 2.4× | 11.61% |
| FY2016 | 2.2× | (27.37%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 1.6× | 13.35% |
| Mar 2026 | 1.4× | 6.79% |
| Dec 2025 | 1.3× | 4.89% |
| Sep 2025 | 1.3× | (6.95%) |
| 39 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| STDN Standard Nuclear Inc compare | 12.9× |
| IOSP Innospec Inc. compare | 2.9× |
| WDFC WD-40 Company compare | 2.6× |
| KWR Quaker Houghton compare | 2.5× |
| HWKN Hawkins, Inc. compare | 2.3× |
| FUL H. B. Fuller Company compare | 1.8× |
| CC The Chemours Company compare | 1.8× |
| NGVT Ingevity Corporation | 1.6× |
| MTX Minerals Technologies Inc. compare | 1.5× |
| Specialty Chemicals industry median | 2.3× |
| Basic Materials sector median | 2.5× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on NGVT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement